EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial.
作者信息
Moerman R V, Arends S, Meiners P M, Brouwer E, Spijkervet F K L, Kroese F G M, Vissink A, Bootsma H
机构信息
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, , Groningen, The Netherlands.
出版信息
Ann Rheum Dis. 2014 Feb;73(2):472-4. doi: 10.1136/annrheumdis-2013-203736. Epub 2013 Aug 12.
Abstract
摘要
Zotero 插件